Health Catalyst Inc
NASDAQ:HCAT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Health Catalyst Inc
NASDAQ:HCAT
|
US |
|
M
|
MSC Industrial Direct Co Inc
F:98M
|
US |
|
Ferrovial SA
F:UFG
|
ES |
|
M
|
MGIC Investment Corp
XMUN:MGC
|
US |
|
P
|
Pernod Ricard SA
XHAM:PER
|
FR |
|
E
|
EchoStar Corp
SWB:E20
|
US |
|
Asahi Group Holdings Ltd
OTC:ASBRF
|
JP |
Wall St Price Targets
HCAT Price Targets Summary
Health Catalyst Inc
According to Wall Street analysts, the average 1-year price target for
HCAT is 1.94 USD with a low forecast of 1.77 USD and a high forecast of 2.1 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is HCAT's stock price target?
Price Target
1.94
USD
According to Wall Street analysts, the average 1-year price target for
HCAT is 1.94 USD with a low forecast of 1.77 USD and a high forecast of 2.1 USD.
What is the Revenue forecast for Health Catalyst Inc?
Projected CAGR
-7%
Over the last 7 years, the compound annual growth rate for Revenue has been 16%. The projected CAGR for the next 3 years is -7%.
What is the Gross Profit forecast for Health Catalyst Inc?
Projected CAGR
-7%
Over the last 7 years, the compound annual growth rate for Gross Profit has been 17%. The projected CAGR for the next 3 years is -7%.